GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Change In Receivables

IPA (ImmunoPrecise Antibodies) Change In Receivables : $-0.47 Mil (TTM As of Oct. 2024)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Change In Receivables?

ImmunoPrecise Antibodies's change in receivables for the quarter that ended in Oct. 2024 was $-1.29 Mil. It means ImmunoPrecise Antibodies's Accounts Receivable increased by $1.29 Mil from Jul. 2024 to Oct. 2024 .

ImmunoPrecise Antibodies's change in receivables for the fiscal year that ended in Apr. 2024 was $-0.18 Mil. It means ImmunoPrecise Antibodies's Accounts Receivable increased by $0.18 Mil from Apr. 2023 to Apr. 2024 .

ImmunoPrecise Antibodies's Accounts Receivable for the quarter that ended in Oct. 2024 was $2.98 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. ImmunoPrecise Antibodies's Days Sales Outstanding for the three months ended in Oct. 2024 was 61.14.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ImmunoPrecise Antibodies's liquidation value for the three months ended in Oct. 2024 was $-14.30 Mil.


ImmunoPrecise Antibodies Change In Receivables Historical Data

The historical data trend for ImmunoPrecise Antibodies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Change In Receivables Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.22 -0.04 0.20 -0.40 -0.18

ImmunoPrecise Antibodies Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.37 -0.19 0.64 -1.29

ImmunoPrecise Antibodies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies  (NAS:IPA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ImmunoPrecise Antibodies's Days Sales Outstanding for the quarter that ended in Oct. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.983/4.452*91
=61.14

2. In Ben Graham's calculation of liquidation value, ImmunoPrecise Antibodies's accounts receivable are only considered to be worth 75% of book value:

ImmunoPrecise Antibodies's liquidation value for the quarter that ended in Oct. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.569-19.834+0.75 * 2.983+0.5 * 1.461
=-14.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies Change In Receivables Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.